Comparison of the Eficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervicogenic Headache

Overview

Cervicogenic headache (CBH) is defined as a headache caused by a disorder in the cervical spine, bones, discs, or soft tissue elements, which is also accompanied by neck pain. Unilateral, non-reversible oculo, fronto, temporal pain, pain that increases with poor neck positioning and incorrect neck movements, and may be seen with restricted movement in the upper cervical and occiput regions. The aim of this thesis is to compare the effectiveness of Mulligan mobilization technique and myofascial release methods used in the treatment of cervicogenic headache through a prospective clinical study.

Detailed description

This study is designed as a prospective, case-control, hospital-based study. Ninety patients aged 18-65 years who present to our hospital with cervicogenic headaches lasting at least 3 months will be included in the study.

Participants will be given full information about the procedure and will provide written informed consent.

The study will be conducted in accordance with the principles outlined in the Helsinki Declaration.

All participants will undergo a comprehensive medical history and a detailed physical examination.

Sociodemographic and clinical data, including age, gender, height, weight, education level, employment status, and income level, will be collected through standardized questionnaires.

A total of 90 patients diagnosed with cervicogenic headache will be randomly assigned to three groups.

Group 1 (n=30) will receive mulligan mobilization therapy three times a week for four weeks (12 sessions total) and a home exercise program.

Group 2 (n=30) will receive myofascial release therapy three times a week for four weeks (12 sessions total), in addition to a home exercise program.

Group 3 (n=30) will receive only a home exercise program three times a week for four weeks (12 sessions total).

All patients will be evaluated at three different time points: before treatment, immediately after treatment is completed, and one month after treatment.

The following assessments will be made during the evaluation process:

To determine the frequency of cervicogenic headaches, patients were given a headache diary.

Head and neck pain in the individuals included in the study was evaluated using the visual analog scale (VAS) before and after treatment.

Participants' functional status was assessed using the headache impact test (HIT-6).

The headache disability inventory/index (HDI) was used to measure the impact of headaches on daily life.

The short form-12 (SF-12) questionnaire was used to assess the patients' quality of life.

Interventions

• Other Mulligan mobilization therapy
  Each patient was asked to sit comfortably, and the therapist performing the treatment stood beside them. The patient's head was free and positioned between the therapist's right forearm and body, with the therapist standing to the patient's right. The therapist then placed their right index, middle, and ring fingers on the base of the occiput and held their right little finger on the spinous process of C2. Next, gentle pressure was applied ventrally and upward (45 degrees) to the lateral edge of
• Other Myofascial release therapy
  The procedure was performed on the upper part of the trapezius muscle and the levator scapulae muscle. The patient was in a seated position, hips higher than knees, feet slightly in front of the knees and in full contact with the ground. The therapist stood behind the patient. Myofascial release of the trapezius was performed unilaterally with a soft fist, while the patient lowered their head forward and slowly rotated, creating a tension line from the middle of the trapezius towards the acrom
• Other Exercise therapy
  All patients were given a home exercise program consisting of neck joint range of motion exercises, trapezius stretches, and isometric strengthening exercises for the neck muscles. The home exercise program was initiated with 3 sets of 10 repetitions per day. The exercises were demonstrated practically by the physician, and all patients were given a printed sheet showing how to perform the exercises. Patients were contacted by phone once a week to inquire about their adherence to the exercise pr

Primary outcome measures

• Frequency of cervicogenic headache [Time frame: Beginning, week 4, and week 8]
• assessment of pain intensity VAS pain (0-10) [Time frame: Beginning, week 4, and week 8]

Secondary outcome measures (3)

• Headache impact scale (HIT) [Time frame: Beginning, week 4, and week 8]
• Headache disability inventory/indexi ( HDI ) [Time frame: Beginning, week 4, and week 8]
• Assessment of quality of life short form-12 [Time frame: Beginning, week 4, and week 8]

Eligibility criteria

Inclusion criteria

• Individuals aged 18-65
• Having experienced neck or headache for 3 months
• Meeting the diagnostic criteria for cervicogenic headache;

• Unilateral pain
• Reduced range of motion in the neck
• Ipsilateral shoulder discomfort
• Ipsilateral arm discomfort
• Pain that worsens with different neck movements and is painful on palpation

Exclusion criteria

• Migraine
• Cluster headache
• Cervical radiculopathy
• Entrapment neuropathy
• Myelopathy
• Rheumatoid arthritis
• Undergoing cervical spinal surgery
• Pregnant women
• Those who received physical therapy within 6 months
• Those with a history of major psychiatric illness
• Those with a history of uncontrolled systemic diseases (cardiovascular, pulmonary, hepatic, renal, hematological)
• Those with a history of uncontrolled systemic endocrine diseases (dm, hyperthyroidism)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation

Randomized

Model

Parallel assignment

Masking

Single blind

Primary purpose

Treatment

Study locations

Turkey (Türkiye) · 1 center

• Konya Beyhekim Eğitim ve Araştırma Hastanesi — Konya

Identifiers

NCT: NCT07508410 · 15520

Primary sources (government registries)

• ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗